MMBG Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Hold
17,115
– – 0.34% 46
2026
Q1
$3.72M Sell
17,115
-27
-0.2% -$5.99K 0.34% 48
2025
Q4
$3.92M Buy
17,142
+27
+0.2% +$6.15K 0.33% 52
2025
Q3
$3.96M Buy
17,115
+8,055
+89% +$1.64M 0.35% 47
2025
Q2
$1.68M Sell
9,060
-2,100
-19% -$390K 0.17% 70
2025
Q1
$2.34M Hold
11,160
– – 0.26% 55
2024
Q4
$1.98M Hold
11,160
– – 0.21% 63
2024
Q3
$2.2M Hold
11,160
– – 0.23% 62
2024
Q2
$1.91M Buy
11,160
+615
+6% +$102K 0.21% 63
2024
Q1
$1.92M Hold
10,545
– – 0.2% 67
2023
Q4
$1.63M Hold
10,545
– – 0.19% 71
2023
Q3
$1.57M Hold
10,545
– – 0.2% 70
2023
Q2
$1.4M Hold
10,545
– – 0.17% 74
2023
Q1
$1.68M Hold
10,545
– – 0.21% 68
2022
Q4
$1.7M Hold
10,545
– – 0.23% 67
2022
Q3
$1.42M Hold
10,545
– – 0.19% 72
2022
Q2
$1.61M Hold
10,545
– – 0.2% 68
2022
Q1
$1.71M Hold
10,545
– – 0.18% 71
2021
Q4
$1.43M Buy
+10,545
New +$1.25M 0.14% 78

Other funds holding ABBV

MMBG Investment Advisors's ABBV Position: Q2 2026 in Review

MMBG Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 17,115 shares worth $4.31M. The position accounts for 0.34% of the portfolio, ranked #46.

MMBG Investment Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MMBG Investment Advisors held 17,115 shares of AbbVie worth $4.31M as of Q2 2026.
  • MMBG Investment Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.34% of MMBG Investment Advisors's portfolio in Q2 2026, its #46 holding.
  • MMBG Investment Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.